Your browser doesn't support javascript.
loading
Determination of an optimal response cut-off able to predict progression-free survival in patients with well-differentiated advanced pancreatic neuroendocrine tumours treated with sunitinib: an alternative to the current RECIST-defined response.
Lamarca, Angela; Barriuso, Jorge; Kulke, Matthew; Borbath, Ivan; Lenz, Heinz-Josef; Raoul, Jean Luc; Meropol, Neal J; Lombard-Bohas, Catherine; Posey, James; Faivre, Sandrine; Raymond, Eric; Valle, Juan W.
Affiliation
  • Lamarca A; Department of Medical Oncology, The Christie NHS Foundation Trust (ENETS Centre of Excellence), Manchester M20 4BX, UK.
  • Barriuso J; Department of Medical Oncology, The Christie NHS Foundation Trust (ENETS Centre of Excellence), Manchester M20 4BX, UK.
  • Kulke M; Faculty of Medical, Biological and Human Sciences, University of Manchester, Manchester M13 9GB, UK.
  • Borbath I; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Lenz HJ; Department of Gastroenterology, Cliniques Universitaires Saint-Luc, Bruxelles 1200, Belgium.
  • Raoul JL; University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA 90033, USA.
  • Meropol NJ; Paoli-Calmettes Institute, Marseille 13009, France.
  • Lombard-Bohas C; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH 44106, USA.
  • Posey J; Flatiron Health, New York, NY 10010, USA.
  • Faivre S; Department of Medical Oncology, Hospices Civils de Lyon Edouard Herriot Hospital, University of Lyon, Lyon 69002, France.
  • Raymond E; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.
  • Valle JW; Department of Medical Oncology, Beaujon University Hospital, Paris 92110, France.
Br J Cancer ; 118(2): 181-188, 2018 01.
Article in En | MEDLINE | ID: mdl-29161241
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Neuroendocrine Tumors / Response Evaluation Criteria in Solid Tumors / Sunitinib Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2018 Type: Article Affiliation country: United kingdom
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Neuroendocrine Tumors / Response Evaluation Criteria in Solid Tumors / Sunitinib Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2018 Type: Article Affiliation country: United kingdom